254 related articles for article (PubMed ID: 24695572)
1. The binding of monomeric C-reactive protein (mCRP) to Integrins αvβ3 and α4β1 is related to its pro-inflammatory action.
Fujita M; Takada YK; Izumiya Y; Takada Y
PLoS One; 2014; 9(4):e93738. PubMed ID: 24695572
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1.
Fujita M; Zhu K; Fujita CK; Zhao M; Lam KS; Kurth MJ; Takada YK; Takada Y
J Biol Chem; 2015 Jan; 290(1):259-71. PubMed ID: 25398877
[TBL] [Abstract][Full Text] [Related]
3. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner.
Saegusa J; Akakura N; Wu CY; Hoogland C; Ma Z; Lam KS; Liu FT; Takada YK; Takada Y
J Biol Chem; 2008 Sep; 283(38):26107-15. PubMed ID: 18635536
[TBL] [Abstract][Full Text] [Related]
5. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
Fujita M; Takada YK; Takada Y
J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.
Eisenhardt SU; Habersberger J; Murphy A; Chen YC; Woollard KJ; Bassler N; Qian H; von Zur Muhlen C; Hagemeyer CE; Ahrens I; Chin-Dusting J; Bobik A; Peter K
Circ Res; 2009 Jul; 105(2):128-37. PubMed ID: 19520972
[TBL] [Abstract][Full Text] [Related]
7. Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion.
Ullah N; Ma FR; Han J; Liu XL; Fu Y; Liu YT; Liang YL; Ouyang H; Li HY
Mol Immunol; 2020 Jan; 117():122-130. PubMed ID: 31765841
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein: how conformational changes influence inflammatory properties.
Eisenhardt SU; Thiele JR; Bannasch H; Stark GB; Peter K
Cell Cycle; 2009 Dec; 8(23):3885-92. PubMed ID: 19887916
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.
Thiele JR; Habersberger J; Braig D; Schmidt Y; Goerendt K; Maurer V; Bannasch H; Scheichl A; Woollard KJ; von Dobschütz E; Kolodgie F; Virmani R; Stark GB; Peter K; Eisenhardt SU
Circulation; 2014 Jul; 130(1):35-50. PubMed ID: 24982116
[TBL] [Abstract][Full Text] [Related]
10. The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin αvβ3.
Yu J; Lee CY; Changou CA; Cedano-Prieto DM; Takada YK; Takada Y
Biochem J; 2017 Feb; 474(4):589-596. PubMed ID: 27993971
[TBL] [Abstract][Full Text] [Related]
11. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells.
Ahrens I; Domeij H; Eisenhardt SU; Topcic D; Albrecht M; Leitner E; Viitaniemi K; Jowett JB; Lappas M; Bode C; Haviv I; Peter K
Basic Res Cardiol; 2011 Sep; 106(5):879-95. PubMed ID: 21562922
[TBL] [Abstract][Full Text] [Related]
12. Fueling the flames of colon cancer - does CRP play a direct pro-inflammatory role?
Køstner AH; Fuglestad AJ; Georgsen JB; Nielsen PS; Christensen KB; Zibrandtsen H; Parner ET; Rajab IM; Potempa LA; Steiniche T; Kersten C
Front Immunol; 2023; 14():1170443. PubMed ID: 37006231
[TBL] [Abstract][Full Text] [Related]
13. Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity.
Karlsson J; Wetterö J; Weiner M; Rönnelid J; Fernandez-Botran R; Sjöwall C
Arthritis Res Ther; 2022 Jun; 24(1):139. PubMed ID: 35690780
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein and inflammation: conformational changes affect function.
Wu Y; Potempa LA; El Kebir D; Filep JG
Biol Chem; 2015 Nov; 396(11):1181-97. PubMed ID: 26040008
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD40L activates soluble and cell-surface integrin αvβ3, α5β1, and α4β1 by binding to the allosteric ligand-binding site (site 2).
Takada YK; Shimoda M; Maverakis E; Felding BH; Cheng RH; Takada Y
J Biol Chem; 2021; 296():100399. PubMed ID: 33571526
[TBL] [Abstract][Full Text] [Related]
16. Acetylcholine Inhibits Monomeric C-Reactive Protein Induced Inflammation, Endothelial Cell Adhesion, and Platelet Aggregation; A Potential Therapeutic?
Slevin M; Iemma RS; Zeinolabediny Y; Liu D; Ferris GR; Caprio V; Phillips N; Di Napoli M; Guo B; Zeng X; AlBaradie R; Binsaleh NK; McDowell G; Fang WH
Front Immunol; 2018; 9():2124. PubMed ID: 30319609
[No Abstract] [Full Text] [Related]
17. The role of C-reactive protein in innate and acquired inflammation: new perspectives.
Trial J; Potempa LA; Entman ML
Inflamm Cell Signal; 2016; 3(2):. PubMed ID: 27738646
[TBL] [Abstract][Full Text] [Related]
18. Native and modified C-reactive protein bind different receptors on human neutrophils.
Heuertz RM; Schneider GP; Potempa LA; Webster RO
Int J Biochem Cell Biol; 2005 Feb; 37(2):320-35. PubMed ID: 15474978
[TBL] [Abstract][Full Text] [Related]
19. A biofunctional review of C-reactive protein (CRP) as a mediator of inflammatory and immune responses: differentiating pentameric and modified CRP isoform effects.
Olson ME; Hornick MG; Stefanski A; Albanna HR; Gjoni A; Hall GD; Hart PC; Rajab IM; Potempa LA
Front Immunol; 2023; 14():1264383. PubMed ID: 37781355
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.
Ullah N; Wu Y
Cell Biochem Biophys; 2022 Dec; 80(4):595-608. PubMed ID: 35997934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
